1、Beijing GoBroad Hospital is located in the second phase of Zhongguancun Life Science Park, with Medical Road in the east, Science Park Road in the south, Sixth Hospital of Beijing Medical Science in the west and Yuhenan Road in the north, covering a land area of about 3.22 hectares.
2、There are, for stage I, 75 beds and 24 beds for quantitative pharmacology in the Drug Clinical Trial Center of Beijing GoBroad Hospital.
3、Build a first class comprehensive international research hospital integrating medicine, teaching, production, learning and research.
4、Beijing GoBroad Hospital gathers well-known experts from all disciplines at home and abroad
1.Assembled a group of renowned Principal Investigators(PI)in the field of hematology.
2.Possesses extensive clinical research experience in cellular immunotherapy.
3.Owns a Central Reference Laboratory.
4.Owns a Phase I Clinical Trial Center covering nearly 1000 square meters,equipped with negative pressure inhalation drug delivery rooms and wards,an electrocardiogram monitoring center,and isotope wards.
5.Includes clinical research wards for both hematology and oncology.
6.Types of isotope research:
a.Early clinical trial design based on isotope quantitative pharmacology.
b.PET receptor imaging technology to evaluate receptor occupancy of new drugs.
c.Application of stable isotope and radioactive isotope tracing technology in new drug research.
1.Located in the Waigaoqiao area of Pudong New District in Shanghai,with a construction area of approximately 60,000 square meters,the hospital has 700 beds in total,with 400 beds available for the Phase I research.
2.Anchored in robust clinical diagnostic and treatment capabilities,as well as extensive expertise in clinical research,the clinical research center integrates resources from Shanghai's innovative pharmaceutical industry.The aim is to establish a research-oriented medical institution that aligns with international standards and caters to the innovation needs of China's biopharmaceutical industry.
3.It has gathered a group of experts renowned both domestically and internationally in the field of oncology,including Professor Li Jin,Professor Han Baohui,Professor Zhou Jun,and others.
1.Located in Fengxian District,it is a comprehensive hospital specializing in the diagnosis and treatment of hemopathy.
2.With 136 beds,including 24 laminar flow rooms for hematopoietic stem cell transplantation,the hospital established several departments like Medical Laboratory,Blood Bank,Medical Imaging and Pharmacy.
3.It is a member institution of the Shanghai Ruijin Hospital Hemopathy Medical Consortium.
4.The hospital has gathered a group of renowned experts in the field of hematopoietic stem cell transplantation,including Professor Wang Chun,Professor Zhu Jun and others.
1.Located in Jing'an District,it is a comprehensive hospital specializing in the diagnosis and treatment of hemopathy.
2.With 128 beds,including 8 laminar flow rooms for Class 100 hematopoietic stem cell transplantation,the hospital established several departments like Medical Laboratory,Blood Bank,Medical Imaging and Pharmacy.
3.It is a member institution of the Shanghai Ruijin Hospital Hemopathy Medical Consortium.
4.The hospital has gathered a group of renowned experts in the field of hematopoietic stem cell transplantation,including Professor Wang Chun,Professor Zhu Jun and others.
1.GoBroad Medical Institute of Hematology (Guangdong Center),Nanfang-Chunfu Children's Institute of Hematology & Oncology,led by Professor Li Chunfu,are conducted on-site at Dongguan Taixin Hospital.
2.Established in 2018,it focuses on research and treatment of hematologic diseases and immune disorders.
3.It currently has 150 beds,36 transplantation units,and has become a globally significant pediatric hematopoietic stem cell transplantation center.
4.By innovating complementary transplantation scheme,the overall survival rate(OS)for thalassemia has reached 97.6%.
Coming Soon
1.Located in the City of Zibo,Shandong Province,this tertiary Grade A hospital is one of the clinical research centers operated by GoBroad Healthcare Group.
2.The institution currently owns a Phase I Clinical Trial Center,along with ten clinical departments including Respiratory Medicine,Gastroenterology,Cardiovascular Medicine,Endocrinology,Burns,and Hematology Clinical Research Center.It is well-equipped to undertake Phase I-IV clinical trial research for new drugs.
3.Each specialized team has strong technology,comprehensive facilities,and a rich patient pool,capable of meeting the requirements of clinical trials across all phases.
